While the Pap identifies the cell changes, the HPV test determines the root cause before those changes even happen. Both tests have saved lives. But they are not interchangeable, and treating them as such puts the patient at risk.
Teal Health raised $10 million in seed funding, taking its total funding to $23 million. The company has submitted an application to the FDA for its at-home cervical cancer screening kit, which seeks to give patients an alternative to the in-office pap smear.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.